These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

915 related items for PubMed ID: 17381667

  • 1. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
    Sokol KC, Knudsen JF, Li MM.
    J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Potential pharmacokinetic interactions affecting antitumor drug disposition in cancer patients.
    Lemachatti J, Levêque D, Beretz L, Bergerat JP.
    Anticancer Res; 2009 Nov; 29(11):4741-4. PubMed ID: 20032429
    [Abstract] [Full Text] [Related]

  • 5. Review of prescription medications in home-based older adults with stroke: a pilot study.
    Classen S, Meuleman J, Garvan C, Ried LD, Mann W, Asal N.
    Res Social Adm Pharm; 2007 Mar; 3(1):104-22. PubMed ID: 17350560
    [Abstract] [Full Text] [Related]

  • 6. The potential for adverse drug reactions in elderly patients.
    Gallagher LP.
    Appl Nurs Res; 2001 Nov; 14(4):220-4. PubMed ID: 11699025
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Drug-drug interactions in oncology: why are they important and can they be minimized?
    Blower P, de Wit R, Goodin S, Aapro M.
    Crit Rev Oncol Hematol; 2005 Aug; 55(2):117-42. PubMed ID: 15890526
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
    Ko Y, Tan SL, Chan A, Wong YP, Yong WP, Ng RC, Lim SW, Salim A.
    Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
    [Abstract] [Full Text] [Related]

  • 11. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Aug; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 12. Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts.
    Caughey GE, Roughead EE, Vitry AI, McDermott RA, Shakib S, Gilbert AL.
    Diabetes Res Clin Pract; 2010 Mar; 87(3):385-93. PubMed ID: 19923032
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of the association between polypharmacy and socioeconomic position among elderly aged > or =77 years in Sweden.
    Haider SI, Johnell K, Thorslund M, Fastbom J.
    Clin Ther; 2008 Feb; 30(2):419-27. PubMed ID: 18343279
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department.
    Hohl CM, Dankoff J, Colacone A, Afilalo M.
    Ann Emerg Med; 2001 Dec; 38(6):666-71. PubMed ID: 11719747
    [Abstract] [Full Text] [Related]

  • 18. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people.
    Haider SI, Johnell K, Weitoft GR, Thorslund M, Fastbom J.
    J Am Geriatr Soc; 2009 Jan; 57(1):62-9. PubMed ID: 19054196
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting.
    Zarowitz BJ, Stebelsky LA, Muma BK, Romain TM, Peterson EL.
    Pharmacotherapy; 2005 Nov; 25(11):1636-45. PubMed ID: 16232025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.